Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04128592
Other study ID # NiNbI-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 30, 2018
Est. completion date May 2020

Study information

Verified date October 2019
Source Hasselt University
Contact Marc Raes, prof. dr.
Phone +32 11 30 84 65
Email marc.raes@jessazh.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Almost 50% of all children have at least 1 episode of noisy breathing before the age of 2 years and almost 25% of these children have more episodes of noisy breathing. The lack of an objective technique for diagnosing noisy breathing children often leads to overrated diagnosis of "wheezing", whereas there may be other noisy breathing phenotypes, like "rattling", that don't favor from the same therapeutic treatment. Presumably, different underlying pathophysiological mechanisms are involved with different biomarker profiles characteristic for different phenotypes. The goal of this study is to optimize the diagnosis of noisy breathing infants and toddlers. Children will be followed for a treatment period of 6 weeks and will visit the paediatrician 3 times (week 0, 3 and 6). During the consultations breath sound analysis will be performed and a breath sample and a nasal mucus will be collected to analyse biomarker profiles. Both methods for diagnosing noisy breathing infants are non-invasive and will be compared to the standard procedure of the paediatrician which consists of auscultation and palpation of the chest. An objective and non-invasive method for diagnosing noisy breathing infants and toddler will pave the way for more cost-effective and personalized prescription of therapies which will increase the quality of life of children with noisy breathing.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 2020
Est. primary completion date March 2020
Accepts healthy volunteers No
Gender All
Age group 2 Months to 18 Months
Eligibility Inclusion Criteria:

- clinical diagnosis of noisy breathing ("wheezing" or "rattling")

Exclusion Criteria:

- born before pregnancy week 37

- congenital or genetic conditions (Down syndrome, Klinefelter's syndrome, …)

- acquired chronic respiratory diseases (bronchopulmonary dysplasy, lung fibrosis, …)

Study Design


Intervention

Device:
diagnosing noisy breathing in infants and toddlers
breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.

Locations

Country Name City State
Belgium Jessa Ziekenhuis Hasselt

Sponsors (3)

Lead Sponsor Collaborator
Hasselt University Jessa Hospital, VITO

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration. week 0
Primary Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation. week 3
Primary Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation. Week 6
Primary exhaled breath volatiles exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) week 0
Primary exhaled breath volatiles exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) week 3
Primary exhaled breath volatiles exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) week 6
Primary respiratory pathogens respiratory pathogens present in a nasopharyngeal swab detected using PCR week 0
Primary respiratory pathogens respiratory pathogens present in a nasopharyngeal swab detected using PCR week 3
Primary respiratory pathogens respiratory pathogens present in a nasopharyngeal swab detected using PCR week 6
Primary level of inflammation markers level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay week 0
Primary level of inflammation markers level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay week 3
Primary level of inflammation markers level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay week 6
Secondary Breath sound recordings evaluated by expert panel of pediatricians Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. week 0
Secondary Breath sound recordings evaluated by expert panel of pediatricians Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. week 3
Secondary Breath sound recordings evaluated by expert panel of pediatricians Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. week 6
Secondary Treatment response assessed by online journal for parents Parents are asked what type of noisy breathing symptoms their child had during the day. Options are: (1) Wheezing; (2) Rattling; (3) Both, but mostly wheezing; (4) Both, but mostly rattling; (5) Both in equal amounts, (6) No noisy breathing today. In the online questionnaire sound fragments of wheezing and rattling are available incase parents are in doubt. week 6
Secondary Recurrence of symptoms assessed by follow up questionnaire Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online 3 months after week 6
Secondary Recurrence of symptoms assessed by follow up questionnaire Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online 6 months after week 6
Secondary Recurrence of symptoms assessed by follow up questionnaire Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online 9 months after week 6
Secondary Recurrence of symptoms assessed by follow up questionnaire Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online 12 months after week 6
See also
  Status Clinical Trial Phase
Recruiting NCT04669288 - AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department Phase 3
Withdrawn NCT04584034 - Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial Phase 4
Terminated NCT02269761 - Chest Ultrasound of ER Patients With Cough or SOB
Enrolling by invitation NCT00775697 - Montelukast in Children With Wheezing Phase 4
Completed NCT00749528 - Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing N/A
Recruiting NCT00494624 - Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children Phase 4
Recruiting NCT06093152 - Video Assisted Study of Salbutamol Response in Viral Wheezing
Completed NCT01452945 - Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing N/A
Withdrawn NCT00628303 - A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants Phase 3
Completed NCT01028560 - Allergy Immunotherapy for the Reduction of Asthma Phase 1/Phase 2
Completed NCT00626808 - A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children Phase 4
Completed NCT00507676 - Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing N/A
Completed NCT03600428 - Safety of LAIV4 in Children With Asthma Phase 4
Recruiting NCT06106646 - Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Recruiting NCT05710081 - Bacterial Lysate In Preventing Asthma Phase 3
Completed NCT04011709 - A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy Early Phase 1
Active, not recruiting NCT03377192 - Impedance Pneumography in Assessment of Asthma Control in Preschool Children
Completed NCT01142505 - Wheeze and Intermittent Treatment Phase 3
Active, not recruiting NCT04942483 - Using Specific Tests in Preschool Children With Wheeze to Help us Determine the Necessity of Inhaled Corticosteroid Therapy (Feasibility Study).
Recruiting NCT05684848 - Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing N/A